Literature DB >> 15293098

Mucosa-associated lymphoid tissue lymphoma (MALT) of salivary glands and scleroderma: a case report.

Monika Prochorec-Sobieszek1, Paweł Mielnik, Teresa Wagner, Hanna Chwalińska-Sadowska.   

Abstract

The connection between scleroderma and lymphoma is uncommon and its pathogenic relationship is a much debated subject. We describe the case of a patient with mucosa-associated lymphoid tissue lymphoma (MALT) of both parotid glands without clinical signs of Sjögren's syndrome who simultaneously developed scleroderma. Independently of the pathogenic mechanism of these two diseases, it seems very important to emphasize that scleroderma may be the first manifestation of lymphoma.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15293098     DOI： 10.1007/s10067-004-0879-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  19 in total

1.  Lymphoma and systemic sclerosis--an uncommon association or possible coincidence of two disorders with a fatal outcome.

Authors:  Y S Haviv; A Ben-Yehuda; A Polliack; R Safadi
Journal:  Eur J Haematol       Date:  1997-09       Impact factor: 2.997

2.  Non-Hodgkin's lymphoma: case control epidemiological study in Yorkshire.

Authors:  R A Cartwright; P A McKinney; C O'Brien; I D Richards; B Roberts; I Lauder; C M Darwin; S M Bernard; C C Bird
Journal:  Leuk Res       Date:  1988       Impact factor: 3.156

3.  Inflammatory and immunomodulatory roles of TGF-beta.

Authors:  S M Wahl; N McCartney-Francis; S E Mergenhagen
Journal:  Immunol Today       Date:  1989-08

4.  Mucosa-associated lymphoid tissue lymphoma of the salivary glands occurring in patients affected by Sjögren's syndrome: report of 6 cases.

Authors:  D Biasi; P Caramaschi; A Ambrosetti; A Carletto; S Mocella; M Randon; L M Bambara
Journal:  Acta Haematol       Date:  2001       Impact factor: 2.195

5.  Acquired disorders affecting the immune system and non-Hodgkin's lymphoma.

Authors:  J M Tielsch; M S Linet; M Szklo
Journal:  Prev Med       Date:  1987-01       Impact factor: 4.018

Review 6.  Rheumatic diseases and malignancy--is there an association?

Authors:  M J Leandro; D A Isenberg
Journal:  Scand J Rheumatol       Date:  2001       Impact factor: 3.641

7.  Uncommon clinical presentation of a lymphocytic lymphoma of intermediate differentiation in a patient with systemic sclerosis.

Authors:  L Baldini; A Guffanti; A Ferrari; D Castagnone; B Mascagni; N Fracchiolla; M Colombi; A T Maiolo
Journal:  Br J Haematol       Date:  1994-03       Impact factor: 6.998

Review 8.  [Systemic scleroderma and malignant diseases. A review of the literature].

Authors:  P Bielefeld
Journal:  Rev Med Interne       Date:  1991 Sep-Oct       Impact factor: 0.728

Review 9.  Mucosa-associated lymphoid tissue lymphoma.

Authors:  P G Isaacson
Journal:  Semin Hematol       Date:  1999-04       Impact factor: 3.851

10.  Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma.

Authors:  B W Needleman; F M Wigley; R W Stair
Journal:  Arthritis Rheum       Date:  1992-01
View more
  2 in total

Review 1.  Non-Hodgkin's lymphoma in systemic sclerosis: case and literature review.

Authors:  Serena Vettori; Stefania Staibano; Massimo Mascolo; Gennaro Ilardi; Gabriele Valentini
Journal:  Clin Rheumatol       Date:  2009-10-07       Impact factor: 2.980

2.  Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature.

Authors:  M Colaci; D Giuggioli; C Vacchi; C Ferri
Journal:  Case Rep Rheumatol       Date:  2017-05-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.